Investor FAQs
ORIC Pharmaceuticals was founded and commenced operations in 2014.
ORIC Pharmaceuticals’ initial public offering (IPO) occurred on April 24, 2020.
ORIC Pharmaceuticals’ fiscal year ends on December 31st.
ORIC Pharmaceuticals is traded on the NASDAQ Global Market under the ticker symbol ORIC, and its CUSIP number is 68622P109.
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
www.computershare.com
US Phone: +1 800 962 4284
International Phone: +1 781 575 312
KPMG LLP
Wilson Sonsini Goodrich & Rosati Professional Corporation
650 Page Mill Road
Palo Alto, CA 94304
+1 650 493 9300
ORIC Pharmaceuticals’ press release archives can be viewed at https://investors.oricpharma.com/news-releases
ORIC Pharmaceuticals’ SEC filings can be viewed at https://investors.oricpharma.com/sec-filings
You can submit queries to ORIC Pharmaceuticals’ investor relations department by contacting investors@oricpharma.com.
OricPharma logo